Stockscreener 앱 받기
47.69
0.02%
-0.01
시간 외 거래:
47.67
-0.02
-0.04%
Tourmaline Bio Inc (TRML) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
-
|
- | - | - |
Operating Expenses
|
7.34%
26.23
|
24.44 | 21.97 | 17.52 |
| Operating Income/Loss |
7.34%
-26.23
|
-24.44 | -21.97 | -17.52 |
| Income/Loss From Continuing Operations Before Tax |
13.84%
-22.97
|
-20.18 | -17.49 | -13.31 |
| Income/Loss From Continuing Operations After Tax |
13.84%
-22.97
|
-20.18 | -17.49 | -13.31 |
|
Net Income/Loss
|
13.84%
-22.97
|
-20.18 | -17.49 | -13.31 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - |
| Basic Average Shares |
0.29%
25.69
|
25.77 | 25.72 | 24.08 |
| Diluted Average Shares |
0.29%
25.69
|
25.77 | 25.72 | 24.08 |
| Basic Earnings Per Share |
14.10%
-0.89
|
-0.78 | -0.68 | -0.55 |
| Diluted Earnings Per Share |
14.10%
-0.89
|
-0.78 | -0.68 | -0.55 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - |
0.25%
0.14%
자본화:
|
볼륨(24시간):